May 23, 2023, the Provincial Center for ADR Monitoring and the Provincial Medical Products Administration visited Zhaoke Pharmaceutical (Hefei) Company Limited (“Zhaoke Hefei”), a subsidiary of Lee’s Pharmaceutical Holdings Limited (“Lee’s Pharm” or “the Group”, HKEx:00950), to conduct on-site assessment. More than 10 pharmaceutical enterprises in Hefei were also invited, including representative enterprises which manufacture drugs selected for VBP, biological medicinal products and Chinese medicine preparations.